News        Sectors        Watchlists

Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT stock forecast: buy or sell

Close on Sep 25th, 2020
$40.09 0.07%
3 months performance
Published: September 27th, 2020 - 17:43

ARCT stock outlook

  • Arcturus Therapeutics closed on Friday at $40.09 (6.94%) prior to reporting financial results at
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the treatment of liver and respiratory care diseases.

Important note:
The thoughts published in this post are personal and should not be followed as recommendations for you to buy or sell shares. The author of this document does not know the particular conditions of the reader, his or her own finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Opinions are published for informational purposes only

ARCT stock charts

Should I buy Arcturus Therapeutics stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is ARCT stock a buy?

Currently, Arcturus Therapeutics stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for ARCT in the next few days, or that it may not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Arcturus Therapeutics stock?

"To sell or not to sell", if you are holding Arcturus Therapeutics stock?. Similarly to when we have to buy shares, determining when is the best time to sell is not a whimsy decision, and we must adhere our own trading style. When selling, as well as buying, detailed strategies are very easy to use but are only applicable for selling shares you already own, not for shorting ARCT stock

A guiding principle is that you should never mantain an operation that generates greater losses than those expected upon purchase. The timing to sell shares should always be ruled by the stop-loss (automatic or manual)

Is it time to sell Arcturus Therapeutics stock?

In the current situation of Arcturus Therapeutics there is not any eligible sell setup, so Arcturus Therapeutics stock holders with operations in profit can keep their positions

Analysts' recommendations to buy or sell Arcturus Therapeutics stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

In the previous 30 days we couldn't find any rating for Arcturus Therapeutics

Technical analysis

SMAs overview

Moving averages are simple tools for traders to detect market momentum. A moving average is calculated as the simple mean of the previous N periods (usually sessions). Moving averages are usually calculated on different periods depending on the trading timeframe 21, 50, 100 and 200 days are the most usual moving averages

ARCT SMAs chart

Supports and resistances

Investors use support and resistance levels to identify price points in the stock price action that may act as barriers, preventing the price of a stock to move up or down. A support level is a level where the price tends to find support as it falls. This means that the price is more likely to "rebound" this level rather than break through it. However, if the price breaks down the support, it will probably continue falling until finding another support level. On the contrary, a resistance level is where the price may find resistance as it rises. Likewise, the price is more liable to "bounce off" at this level, and if it finally breaks this level, it will climb more easily until it meets the next resistance

The current resistances are:

  • R1: $45.50 (13.49% above)
  • R2: $46.56 (16.14% above)
  • R3: $47.66 (18.88% above)
  • The current support levels are:

  • S1: $35.05 (-12.57% below)
  • S2: $34.59 (-13.72% below)
  • S3: $29.31 (-26.89% below)
  • Bollinger bands

    So-called Bollinger bands are a widely known technical strategy introduced by John Bollinger. By essence, the Bollinger Bands are lines that run around a centralmoving average, ranging the distance from the bottom to the top depending on market volatility. They are usually plotted by an interval of two standard deviations, above and below, from a moving average line. Bollinger himself recommends the moving average period to be 20

    ARCT RSI chart

    Relative strength index

    The relative strength index (RSI) is a technical indicator used in the analysis of financial markets. Its objective is to chart the current and past strength or weakness of a stock or market based on the closing prices of a recent trading period. Like other oscillation indicators, the RSI moves in a range between 0 and 100. J. Welles Wilder introduced the relative strength indicator in the late 1970s and since then it has been widely used by investors

    The Relative Strength Indicator has been between the levels of 70 and 30 for some weeks, and therefore, without this indicator really being of any help to us in making any decisions.

    ARCT RSI chart

    Earnings and financials

    Arcturus Therapeutics Holdings Inc. (ARCT) published second-quarter earnings of $-0.55 per share, matching the Market consensus estimate of $-0.55 per share. The company reported revenue for Q2 was $2.3 million in line with analysts' forecasts as well.

    Compared to the same quarter last year, EPS was $-0.07, so reported EPS means a drop of -685.71%. Revenue sank a -77.13% on an annualized basis in the second-quarter, from $10.2M to $2.3M last quarter.

    ARCT posts financial report. Earnings reporting day has a more than usual risk for traders as the results published can soar and sink the stock price with exceptionally low liquidity and not honouring your buy or stop-loss orders. Check company's website to confirm time and details on the earnings call and the earnings report.

    ARCT revenues and profits chart